Related Experiment Videos

Long-term follow-up of children prenatally exposed to ritodrine

British Journal of Obstetrics and Gynaecology
|February 1, 1986
PubMed

Insights

Ritodrine treatment during pregnancy did not affect children's physical or neurological development. However, some studies suggest potential impacts on school performance, though the cause remains unclear.

Area of Science:

  • Obstetrics and Gynecology
  • Pediatric Neurology
  • Developmental Psychology

Background:

  • Ritodrine is a tocolytic agent used to prevent preterm labor.
  • Concerns exist regarding the long-term effects of prenatal medication exposure on child development.

Purpose of the Study:

  • To evaluate the developmental outcomes of children exposed to ritodrine in utero.
  • To compare physical, neurological, and behavioral parameters between exposed and control groups.

Main Methods:

  • A cohort of 78 children exposed to ritodrine during pregnancy was compared to two matched control groups.
  • Evaluated parameters included urinalysis, physical measurements (length, weight, head circumference), neurological assessments, and behavioral observations by parents and teachers.

Main Results:

  • No statistically significant differences were observed in urinalysis, physical development, neurological findings, or general behavior between the ritodrine-exposed group and controls.
  • Teachers perceived slightly lower school performance in children exposed to ritodrine.

Conclusions:

  • Prenatal ritodrine exposure did not appear to cause significant short-term adverse effects on physical or neurological development.
  • The observed difference in school performance warrants further investigation to determine if it is linked to ritodrine or the obstetric conditions necessitating its use.

Related Concept Videos